Expert Pitch
Rutgers University-New Brunswick

Rutgers Experts Available to Discuss Environmental Protection During COVID-19 Crisis

15-Apr-2020 9:00 AM EDT, by Rutgers University-New Brunswick

New Brunswick, N.J. (April 15, 2020) – Rutgers University–New Brunswick professors Nicole Fahrenfeld and John Reinfelder are available for interviews on environmental protection issues during the COVID-19 pandemic.

Fahrenfeld can discuss issues including microbial water quality, sewer issues (including what shouldn’t be flushed), wastewater-based epidemiology, combined sewer overflows, the One Water movement, the One Health Initiative and private well water quality.

“New Jersey’s wastewater treatment plants are designed to remove things from the water that are supposed to be drained and flushed, such as urine and feces, soap from hand- and dish-washing and toilet paper,” according to Fahrenfeld, an associate professor in the Department of Civil and Environmental Engineering in the School of Engineering. “Therefore, it is especially important at a time like this that people maintain their normal healthy environmental practices by not disposing of items like wipes, sanitary napkins, pharmaceuticals and toxic chemicals in sinks and/or toilets.”

Reinfelder can discuss possible “blue water days” in urban waterways due to a decrease in domestic and industrial water use, and potentially higher volumes of wastewater discharged to waterways in suburban areas as large numbers of people stay home. He can also discuss the higher concentrations of antibiotics and other pharmaceutical compounds in wastewater and the possible short- and longer-term effects of the relaxation of current environmental regulations.

“The current period of reduced human activity needed to reduce the effects of the spread of COVID-19 on public health may give environmental scientists and managers an opportunity to evaluate the impacts of everyday activities associated with wastewater discharges on the health of rivers, estuaries and the coastal ocean,” according to Reinfelder, a professor in the Department of Environmental Sciences in the School of Environmental and Biological Sciences.

Their comments are included in a story on the Rutgers Institute of Earth, Ocean, and Atmospheric Sciences website: https://eoas.rutgers.edu/mother-earth-another-covid-19-victim/

                                                                      ###

Broadcast interviews: Rutgers University has broadcast-quality TV and radio studios available for remote live or taped interviews with Rutgers experts. For more information, contact Neal Buccino at neal.buccino@echo.rutgers.edu

ABOUT RUTGERS—NEW BRUNSWICK
Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship is a leading public research institution and a member of the prestigious Association of American Universities. It has an internationally acclaimed faculty, 12 degree-granting schools and the Big Ten Conference’s most diverse student body.




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
3.36135